Two engines in one: MC90² brainstorms strategic initiatives at scale, then breaks them down into compliance-filtered 90-day execution plans — per rep, per account. Full compliance, full audit, continuous learning.
A 30-day initiative becomes a brainstormed plan, compliance-filtered execution, and role-based action — all in one platform.
Across global commercial organizations, the same five symptoms keep surfacing — regardless of region, brand, or therapy area.
MC90 is built around measurable outcomes — not features. Every recommendation, every alert, every nudge is anchored to one of four business levers.
MC90² is a Patent-Pending Agentic Commercial Execution Platform purpose-built for Pharma & MedTech. Two engines in one — a Brainstorm Engine that generates strategic initiatives at infinite scale, and an Execution Engine that converts the winners into compliance-filtered 90-day plans, per rep, per account. Eleven specialized agents coordinate through a proprietary orchestration layer to produce auditable, compliance-safe, action-ready outputs.
MC90 delivers its output through dedicated dashboards — one for the rep, one for the manager, one for the executive. Each role sees the same underlying intelligence, framed for the decisions they actually own.
Veraniqs is an early-stage company with a working product, currently engaging with leading global pharma in pilot conversations. We believe pharma commercial execution deserves the same rigor that pharma R&D already has.
Two engines in one. The Brainstorm Engine generates strategic commercial initiatives at infinite scale. The Execution Engine converts the winning initiatives into compliance-filtered 90-day plans — per rep, per account. Aktana recommends. We brainstorm and execute.
Our approach is to make AI invisible: the user works with simple, clear outputs — and the complexity sits underneath, doing the heavy lifting.
Veraniqs is selected for partner programs across the AI and cloud ecosystem — and operates under a US Provisional Patent.
We are selectively engaging with pharmaceutical leaders to explore where MC90 can add measurable value. A 30-minute introduction call — no commitments, just understanding.